Julie A. Rudnicki ’89 has been named Global Project Leader-Oncology by Bayer Pharmaceuticals.
She now coordinates the firm’s worldwide pharmaceutical efforts and has recently visited Hong Kong, Berlin and Scandinavia. Her current efforts focus on further approval of an existing drug to treat liver cancer, Nexavar.
Rudnicki earned her bachelor’s degree with honors in biology minored in English minor, received the Lawrie Medal for excellence in biology and was a member of Sigma Xi and the soccer and crew teams.
She earned her Ph.D. from Cornell University’s Graduate School of Medical Sciences.